Your browser doesn't support javascript.
loading
Reduction in antidrug antibody levels after switching to rituximab in patients with rheumatoid arthritis with prior infliximab or adalimumab secondary failure.
Martínez Feito, Ana; Plasencia-Rodríguez, Chamaida; Navarro-Compán, Victoria; Hernández-Breijo, Borja; Nozal, Pilar; Ángeles González, María; Nuño, Laura; Monjo, Irene; Pascual-Salcedo, Dora; Balsa, Alejandro.
Afiliação
  • Martínez Feito A; Immuno-Rheumatology group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain; Immunology Unit, La Paz University Hospital, Madrid, Spain. Electronic address: amartinezf@salud.madrid.org.
  • Plasencia-Rodríguez C; Immuno-Rheumatology group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain; Rheumatology Department, La Paz University Hospital, Madrid, Spain.
  • Navarro-Compán V; Immuno-Rheumatology group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain; Rheumatology Department, La Paz University Hospital, Madrid, Spain.
  • Hernández-Breijo B; Immuno-Rheumatology group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Nozal P; Immunology Unit, La Paz University Hospital, Madrid, Spain.
  • Ángeles González M; Immunology Unit, La Paz University Hospital, Madrid, Spain.
  • Nuño L; Rheumatology Department, La Paz University Hospital, Madrid, Spain.
  • Monjo I; Rheumatology Department, La Paz University Hospital, Madrid, Spain.
  • Pascual-Salcedo D; Immuno-Rheumatology group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Balsa A; Immuno-Rheumatology group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain; Rheumatology Department, La Paz University Hospital, Madrid, Spain.
Semin Arthritis Rheum ; 50(1): E1-E2, 2020 02.
Article em En | MEDLINE | ID: mdl-31375255

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Adalimumab / Rituximab / Infliximab / Anticorpos Limite: Humans Idioma: En Revista: Semin Arthritis Rheum Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Adalimumab / Rituximab / Infliximab / Anticorpos Limite: Humans Idioma: En Revista: Semin Arthritis Rheum Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos